{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:36:50Z","timestamp":1783769810249,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.radonc.2022.07.023","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T11:19:54Z","timestamp":1660216794000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factors"],"prefix":"10.1016","volume":"175","author":[{"given":"Sri Harsha","family":"Kombathula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthea","family":"Cree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya V.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa H.","family":"Barraclough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Haslett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.07.023_b0005","unstructured":"Early Diagnosis [Internet]. [cited 2022 May 16]. Available from: https:\/\/crukcancerintelligence.shinyapps.io\/EarlyDiagnosis\/."},{"key":"10.1016\/j.radonc.2022.07.023_b0010","first-page":"405","article-title":"Epidemiology of cervical cancer with special focus on India","volume":"16","author":"Sreedevi","year":"2015","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.radonc.2022.07.023_b0015","doi-asserted-by":"crossref","first-page":"e007690","DOI":"10.1136\/bmjopen-2015-007690","article-title":"Social, demographic and healthcare factors associated with stage at diagnosis of cervical cancer: cross-sectional study in a tertiary hospital in Northern Uganda","volume":"6","author":"Mwaka","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2022.07.023_b0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(79)91212-4","article-title":"Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers","volume":"5","author":"Boulware","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.023_b0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0090-8258(83)90016-1","article-title":"Once-monthly radiotherapy for the palliation of pelvic gynecological malignancy","volume":"16","author":"Hodson","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0030","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/0360-3016(86)90130-6","article-title":"1000 Gy single dose palliation for advanced carcinoma of the cervix or endometrium","volume":"12","author":"Halle","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.023_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/gyno.2001.6233","article-title":"10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri","volume":"82","author":"Onsrud","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0040","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0360-3016(87)90314-2","article-title":"Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I\/II study","volume":"13","author":"Spanos","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.023_b0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0360-3016(89)90120-X","article-title":"Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502","volume":"17","author":"Spanos","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.023_b0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0360-3016(93)90059-5","article-title":"Effect of rest interval on tumor and normal tissue response\u2013a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502)","volume":"25","author":"Spanos","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.023_b0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clon.2011.01.001","article-title":"A hypofractionated radiotherapy regimen (0-7-21) for advanced gynaecological cancer patients","volume":"23","author":"Yan","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2022.07.023_b0060","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B","article-title":"Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure","volume":"74","author":"Corn","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.07.023_b0065","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/IGC.0000000000001313","article-title":"Radiotherapy improves the survival of patients with metastatic cervical cancer: a propensity-matched analysis of SEER database","volume":"28","author":"Huang","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2022.07.023_b0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13566-012-0050-y","article-title":"Palliative pelvic radiotherapy for gynaecologic cancer","volume":"1","author":"Skliarenko","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13224-016-0926-7","article-title":"Fractionated palliative pelvic radiotherapy as an effective modality in the management of recurrent\/refractory epithelial ovarian cancers: an institutional experience","volume":"67","author":"Bansal","year":"2017","journal-title":"J Obstet Gynaecol India"},{"key":"10.1016\/j.radonc.2022.07.023_b0080","first-page":"1288","article-title":"Association of definitive pelvic radiation therapy with survival among patients with newly diagnosed metastatic cervical cancer","volume":"4","author":"Wang","year":"2018","journal-title":"JAMAOncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13014-019-1297-x","article-title":"Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer","volume":"14","author":"Yin","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jso.2930340213","article-title":"Haemostatic and antialgic effects of the 25 MV photon beam concentrated dose in the treatment of carcinoma of the cervix","volume":"34","author":"Patr\u00edcio","year":"1987","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0095","article-title":"Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy","volume":"2","author":"Fujiwara","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2022.07.023_b0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/gyno.2000.6059","article-title":"Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum","volume":"80","author":"Firat","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/srao.2000.6595","article-title":"Fractionation and outcomes with palliative radiation therapy","volume":"10","author":"Anderson","year":"2000","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/healthcare9010098","article-title":"Cost analysis of selected radiotherapeutic modalities for prostate cancer treatment\u2014czech republic case study for the purposes of hospital based HTA","volume":"9","author":"Hospodkov\u00e1","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.radonc.2022.07.023_b0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2021.11.035","article-title":"Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation","volume":"166","author":"Spencer","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13014-022-01995-7","article-title":"Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy","volume":"17","author":"Moradi","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0125","first-page":"40","article-title":"Short-course palliative radiation therapy leads to excellent bleeding control: a single centre retrospective study","volume":"22","author":"Sapienza","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/0973-1482.19588","article-title":"Monthly palliative pelvic radiotherapy in advanced carcinoma of uterine cervix","volume":"1","author":"Mishra","year":"2005","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2022.07.023_b0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3857\/roj.2013.31.4.216","article-title":"Short-course palliative radiotherapy for uterine cervical cancer","volume":"31","author":"Kim","year":"2013","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2022.07.023_b0140","first-page":"1033","article-title":"Radiation therapy for patients with bone metastasis from uterine cervical cancer: its role and optimal radiation regimen for palliative care","volume":"38","author":"Hata","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2022.07.023_b0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpainsymman.2020.08.011","article-title":"A retrospective study of rapid symptom response in bleeding gynecologic malignancies with short course palliative radiation therapy: less is more","volume":"61","author":"Butala","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.radonc.2022.07.023_b0150","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2009.22.4659","article-title":"Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3802\/jgo.2011.22.1.44","article-title":"Clinical significance of HIF-2\u03b1 immunostaining area in radioresistant cervical cancer","volume":"22","author":"Kim","year":"2011","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijrobp.2004.03.025","article-title":"Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma","volume":"60","author":"Ishikawa","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.023_b0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2009.10.062","article-title":"Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study","volume":"116","author":"Liao","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2022.07.023_b0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1054\/bjoc.2000.1319","article-title":"Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix","volume":"83","author":"Loncaster","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2022.07.023_b0175","first-page":"13261","article-title":"Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022042219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022042219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:21:38Z","timestamp":1759123298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022042219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":35,"alternative-id":["S0167814022042219"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.07.023","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factors","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}